Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study (Q40153944)

18 September 2017

Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study (English)

1 reference

18 September 2017

Poupak Fallahi

1

1 reference

18 September 2017

Silvia Martina Ferrari

series ordinal

2

1 reference

18 September 2017

Alessandro Antonelli

series ordinal

3

1 reference

18 September 2017

31 December 2015

1 reference

18 September 2017

1 reference

18 September 2017

52

1 reference

18 September 2017

597-601

1 reference

18 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-015-0836-y

18 September 2017

0 references

cites work

Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Autoimmune thyroid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

When thyroid hormone replacement is ineffective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Drugs affecting thyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Conditions and drugs interfering with thyroxine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Thyroxine softgel capsule in patients with gastric-related T4 malabsorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Altered intestinal absorption of L-thyroxine caused by coffee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

The administration of L-thyroxine as soft gel capsule or liquid solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Intergenerational effects of prenatal ethanol on glucose tolerance and insulin response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

A systematic review of drug absorption following bariatric surgery and its theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0836-Y

Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients

21 January 2018

1 reference

12 December 2020

Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms

1 reference

12 December 2020

Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism

1 reference

12 December 2020

Levothyroxine liquid solution versus tablet for replacement treatment in hypothyroid patients

1 reference

12 December 2020

Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism

1 reference

12 December 2020

Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis

1 reference

12 December 2020

Atypical celiac disease as cause of increased need for thyroxine: a systematic study

1 reference

12 December 2020

Delayed intestinal absorption of levothyroxine

1 reference

12 December 2020

Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution

1 reference

12 December 2020

10.1007/S12020-015-0836-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference